223 related articles for article (PubMed ID: 24427762)
41. Live-Attenuated VEEV Vaccine Delivered by iDNA Using Microneedles Is Immunogenic in Rabbits.
Tretyakova I; Tomai M; Vasilakos J; Pushko P
Front Trop Dis; 2022 Mar; 3():. PubMed ID: 37854093
[TBL] [Abstract][Full Text] [Related]
42. Skin delivery of trivalent Sabin inactivated poliovirus vaccine using dissolvable microneedle patches induces neutralizing antibodies.
Donadei A; Kraan H; Ophorst O; Flynn O; O'Mahony C; Soema PC; Moore AC
J Control Release; 2019 Oct; 311-312():96-103. PubMed ID: 31484041
[TBL] [Abstract][Full Text] [Related]
43. Responsive Microneedles as a New Platform for Precision Immunotherapy.
Liu X; Song H; Sun T; Wang H
Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242649
[TBL] [Abstract][Full Text] [Related]
44. Targeting the skin for microneedle delivery of influenza vaccine.
Koutsonanos DG; Compans RW; Skountzou I
Adv Exp Med Biol; 2013; 785():121-32. PubMed ID: 23456844
[TBL] [Abstract][Full Text] [Related]
45. Microneedle patch delivery to the skin of virus-like particles containing heterologous M2e extracellular domains of influenza virus induces broad heterosubtypic cross-protection.
Kim MC; Lee JW; Choi HJ; Lee YN; Hwang HS; Lee J; Kim C; Lee JS; Montemagno C; Prausnitz MR; Kang SM
J Control Release; 2015 Jul; 210():208-16. PubMed ID: 26003039
[TBL] [Abstract][Full Text] [Related]
46. Influenza subunit vaccine coated microneedle patches elicit comparable immune responses to intramuscular injection in guinea pigs.
Kommareddy S; Baudner BC; Bonificio A; Gallorini S; Palladino G; Determan AS; Dohmeier DM; Kroells KD; Sternjohn JR; Singh M; Dormitzer PR; Hansen KJ; O'Hagan DT
Vaccine; 2013 Jul; 31(34):3435-41. PubMed ID: 23398932
[TBL] [Abstract][Full Text] [Related]
47. Induction of broad immunity by thermostabilised vaccines incorporated in dissolvable microneedles using novel fabrication methods.
Vrdoljak A; Allen EA; Ferrara F; Temperton NJ; Crean AM; Moore AC
J Control Release; 2016 Mar; 225():192-204. PubMed ID: 26774221
[TBL] [Abstract][Full Text] [Related]
48. Microneedle patches: usability and acceptability for self-vaccination against influenza.
Norman JJ; Arya JM; McClain MA; Frew PM; Meltzer MI; Prausnitz MR
Vaccine; 2014 Apr; 32(16):1856-62. PubMed ID: 24530146
[TBL] [Abstract][Full Text] [Related]
49. Microneedle arrays for vaccine delivery: the possibilities, challenges and use of nanoparticles as a combinatorial approach for enhanced vaccine immunogenicity.
Rodgers AM; Cordeiro AS; Kissenpfennig A; Donnelly RF
Expert Opin Drug Deliv; 2018 Sep; 15(9):851-867. PubMed ID: 30051726
[TBL] [Abstract][Full Text] [Related]
50. Stability of influenza vaccine coated onto microneedles.
Choi HJ; Yoo DG; Bondy BJ; Quan FS; Compans RW; Kang SM; Prausnitz MR
Biomaterials; 2012 May; 33(14):3756-69. PubMed ID: 22361098
[TBL] [Abstract][Full Text] [Related]
51. Microneedle arrays coated with charge reversal pH-sensitive copolymers improve antigen presenting cells-homing DNA vaccine delivery and immune responses.
Duong HTT; Kim NW; Thambi T; Giang Phan VH; Lee MS; Yin Y; Jeong JH; Lee DS
J Control Release; 2018 Jan; 269():225-234. PubMed ID: 29154976
[TBL] [Abstract][Full Text] [Related]
52. Effect of zymosan and poly (I:C) adjuvants on responses to microneedle immunization coated with whole inactivated influenza vaccine.
Shin JH; Noh JY; Kim KH; Park JK; Lee JH; Jeong SD; Jung DY; Song CS; Kim YC
J Control Release; 2017 Nov; 265():83-92. PubMed ID: 28890214
[TBL] [Abstract][Full Text] [Related]
53. Microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy.
Al-Zahrani S; Zaric M; McCrudden C; Scott C; Kissenpfennig A; Donnelly RF
Expert Opin Drug Deliv; 2012 May; 9(5):541-50. PubMed ID: 22475249
[TBL] [Abstract][Full Text] [Related]
54. Induction of CD8(+) T cell responses and protective efficacy following microneedle-mediated delivery of a live adenovirus-vectored malaria vaccine.
Pearson FE; O'Mahony C; Moore AC; Hill AV
Vaccine; 2015 Jun; 33(28):3248-55. PubMed ID: 25839104
[TBL] [Abstract][Full Text] [Related]
55. Implantable microneedles with an immune-boosting function for effective intradermal influenza vaccination.
Chen YH; Lai KY; Chiu YH; Wu YW; Shiau AL; Chen MC
Acta Biomater; 2019 Oct; 97():230-238. PubMed ID: 31362139
[TBL] [Abstract][Full Text] [Related]
56. Immune responses induced by inactivated porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in neonatal pigs using different adjuvants.
Vreman S; Stockhofe-Zurwieden N; Popma-de Graaf DJ; Savelkoul HFJ; Barnier-Quer C; Collin N; Collins D; McDaid D; Moore AC; Rebel JMJ
Vet Immunol Immunopathol; 2021 Feb; 232():110170. PubMed ID: 33383553
[TBL] [Abstract][Full Text] [Related]
57. Electroporation of a nanoparticle-associated DNA vaccine induces higher inflammation and immunity compared to its delivery with microneedle patches in pigs.
Bernelin-Cottet C; Urien C; McCaffrey J; Collins D; Donadei A; McDaid D; Jakob V; Barnier-Quer C; Collin N; Bouguyon E; Bordet E; Barc C; Boulesteix O; Leplat JJ; Blanc F; Contreras V; Bertho N; Moore AC; Schwartz-Cornil I
J Control Release; 2019 Aug; 308():14-28. PubMed ID: 31265882
[TBL] [Abstract][Full Text] [Related]
58. Vaccination with human papillomavirus pseudovirus-encapsidated plasmids targeted to skin using microneedles.
Kines RC; Zarnitsyn V; Johnson TR; Pang YY; Corbett KS; Nicewonger JD; Gangopadhyay A; Chen M; Liu J; Prausnitz MR; Schiller JT; Graham BS
PLoS One; 2015; 10(3):e0120797. PubMed ID: 25785935
[TBL] [Abstract][Full Text] [Related]
59. Advances in Antimicrobial Microneedle Patches for Combating Infections.
Jamaledin R; Yiu CKY; Zare EN; Niu LN; Vecchione R; Chen G; Gu Z; Tay FR; Makvandi P
Adv Mater; 2020 Aug; 32(33):e2002129. PubMed ID: 32602146
[TBL] [Abstract][Full Text] [Related]
60. Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature.
Vassilieva EV; Kalluri H; McAllister D; Taherbhai MT; Esser ES; Pewin WP; Pulit-Penaloza JA; Prausnitz MR; Compans RW; Skountzou I
Drug Deliv Transl Res; 2015 Aug; 5(4):360-71. PubMed ID: 25895053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
